Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. MU
2. QCOM
3. USO
4. CBRS
5. HTZ
6. FDX
7. SPY
8. KBH
9. LAES
10. MRK

Go back to Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder
(NASDAQ: CMND) Delayed: 2.68 --0 (-0%)
Previous Close $2.68    52 Week High $ 
Open $2.68    52 Week Low $ 
Day High $2.68    P/E N/A 
Day Low $2.68    EPS $ 
Volume 2,135